Fang, F., Song, T., Wu, Q., Cui, Y., Zhang, W., Yu, G., Mu, H., Liu, C., Chen, P., Bao, X., Li, G. (2025). Sintilimab combined with lenvatinib versus hepatic artery infusion chemotherapy (HAIC) for neoadjuvant treatment of resectable primary hepatocellular carcinoma with high risk of recurrence: A prospective, two-arm, randomized, phase II clinical study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16301